News

Pay talks stall as GPC launches legal challenge

24-Apr-08

Talks on the promised 1.5 per cent practice income increase have collapsed, while the GPC challenges the legality of the Doctors’ and Dentists’ Review Body (DDRB) report.

The DDRB proposed a 2.7 per cent increase across the profession. But cuts to correction factors mean that 90 per cent of practices will see no rise, and the average gain across the whole profession will be just 0.2 per cent.

It is unclear how much more must be spent to reach the 1.5 per cent offer for England, Scotland, possibly Wales and not Northern Ireland. Talks are on hold pending the outcome of the challenge.

DoH lawyers are now considering the challenge.

BMA chairman Dr Hamish Meldrum wrote to health secretary Alan Johnson to express the BMA's ‘serious concerns that the report is not legally deliverable under current regulations'.

The challenge centres on the DDRB's recommendation that paragraph 1.6 of the 2006/7 contract revisions apply in full. The passage proposes that practices should over time become less reliant on MPIG.

GPC negotiator Dr Chaand Nagpaul said: ‘It's three lines that went into no detail weighted against the legal directions contained in the SFA.'

jonn.elledge@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

A question of capacity

Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more

Workplace-based assessment

The WPBA should be seen as a developmental process, says the RCGP's Dr Jane Mamelok. Read more

Professional development - The role of an educational supervisor

Working as an educational supervisor can be stimulating and rewarding, says Dr Alexander Williams. Read more

Show all articles

 

Latest Clinical Articles

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Clinical Review - Headache in children

Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more

Carpal tunnel syndrome

Section 1: Epidemiology and aetiology Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week